Carolina Pavlovsky
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial.
Journal: Leukemia
Published: March 30, 2026
The adverse prognostic impact of HMGCLL1 gene variants can be abrogated by frontline second-generation tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.
Journal: Leukemia
Published: September 08, 2025
Evaluation of leukemic stem cell (CD26 +) in chronic myeloid leukemia patients with different molecular responses and in treatment-free remission.
Journal: Clinical and experimental medicine
Published: January 16, 2025
Bringing global hematology research to the forefront.
Journal: Blood advances
Published: January 11, 2024
Long-Term Follow-Up in Patients With Chronic Myeloid Leukemia Treated With Ponatinib in a Real-World Cohort: Safety and Efficacy Analysis.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 14, 2023
Inequalities in access to treatment in Argentina: Differences in management of CLL and multiple myeloma?
Journal: Seminars in hematology
Published: June 03, 2023
Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal.
Journal: Journal of hematology & oncology
Published: January 16, 2023
Last Updated: 09/26/2026